EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Gentiopicroside Regulates EGFR and Induces Its Lysosomal Degradation to Attenuate Heart Failure

Gentiopicrosid reguliert EGFR und induziert dessen lysosomalen Abbau zur Abschwächung der Herzinsuffizienz

Mingzhen Cao, Da Ke, Jian Ni, Yuan Yuan, Zhang Nan iD, Xiujun Dai, Heng Zhou iD

Phytotherapy Research · 2026-11 · 40 (11) · 6670-6684

DOI: 10.1002/ptr.70452 ↗

Auf einen Blick

In Maus- und Zellmodellen verringerte Gentiopicrosid (GPS) die durch Druckbelastung bzw. Ang II ausgelöste kardiale Hypertrophie und Fibrose. Der Effekt ging mit einem lysosomalen EGFR-Abbau einher.

Fragestellung

Welche Rolle spielt Gentiopicrosid bei kardialer Hypertrophie und Herzinsuffizienz, und über welchen Mechanismus wirkt es auf EGFR?

Methode

C57BL/6-Mäuse mit transversaler Aortenokklusion (TAC) und NRVMs/NRCFs wurden mit GPS untersucht; zusätzlich EGFR-Knockdown, CETSA sowie lysosomale/proteasomale Hemmung und Canertinib.

Ergebnisse

GPS schwächte TAC-induzierte kardiale Hypertrophie und Fibrose in vivo ab und hemmte Ang-II-induzierte Kardiomyozytenhypertrophie. Zudem reduzierte GPS Apoptose und oxidativen Stress; EGFR-Depletion hob den Schutz auf.

Schlussfolgerung der Autor:innen

Die Autor:innen schlussfolgern, dass GPS als Regulator der EGFR-Stabilität wirkt, lysosomalen EGFR-Abbau fördert und dadurch kardiale Hypertrophie und Remodeling abschwächt.

Kernaussagen

  • GPS verringerte kardiale Hypertrophie und Fibrose in vivo.
  • Der Effekt beruhte auf lysosomalem EGFR-Abbau.
  • EGFR-Depletion hob den protektiven Effekt von GPS auf.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 20.09.2026. Verfasst von Mingzhen Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: ErbB Receptors, Iridoid Glucosides, Heart Failure, Lysosomes. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Health Commission of Hubei Province scientific research project.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac hypertrophy is a major pathological response to cardiovascular stress and a critical contributor to heart failure (HF). Gentiopicroside (GPS), a naturally occurring iridoid glycoside derived from Gentiana scabra, exhibits anti‐inflammatory, antioxidant, and anti‐fibrotic properties. However, its role and molecular mechanisms in cardiac hypertrophy and HF remain unclear. A pressure overload‐induced cardiac remodeling model was established in C57BL/6 mice by transverse aortic constriction (TAC), followed by GPS treatment with or without the EGFR tyrosine kinase inhibitor Canertinib. Cardiac function and remodeling were evaluated by echocardiography, hemodynamic analysis, and histological staining. In vitro, neonatal rat ventricular myocytes (NRVMs) and cardiac fibroblasts (NRCFs) were used to investigate the cellular effects of GPS. EGFR knockdown, conditioned medium transfer, cellular thermal shift assay (CETSA), and lysosomal/proteasomal inhibition experiments were performed to elucidate the mechanism underlying GPS‐mediated EGFR regulation. GPS markedly alleviated TAC‐induced cardiac hypertrophy and fibrosis in vivo and suppressed Ang II‐induced cardiomyocyte hypertrophy. GPS also reduced cardiomyocyte apoptosis and oxidative stress. Mechanistically, GPS acted as an EGFR degrader rather than a conventional kinase inhibitor, reducing total EGFR abundance without inhibiting the kinase activity of remaining receptors, thereby attenuating excessive AKT/ERK1/2 signaling. CETSA and molecular docking indicated direct GPS–EGFR interaction. GPS‐induced EGFR reduction was mediated primarily through lysosomal degradation, as demonstrated by chloroquine rescue experiments, whereas proteasome inhibition had limited effects. Co‐administration of Canertinib with GPS conferred no additional benefit. EGFR depletion abolished the protective effect of GPS in cardiomyocytes, indicating a cardiomyocyte‐autonomous mechanism. This study identifies GPS as a regulator of EGFR stability during pathological cardiac remodeling. By promoting lysosome‐dependent EGFR degradation and suppressing excessive AKT/ERK1/2 signaling, GPS attenuates cardiac hypertrophy and remodeling while preserving basal EGFR function, highlighting its potential therapeutic value for HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsIridoid GlucosidesHeart FailureLysosomesAnimalsMice, Inbred C57BLMyocytes, CardiacMaleMiceRatsCardiomegalyOxidative StressVentricular RemodelingApoptosisSignal TransductionRats, Sprague-Dawley

Substanzen

ErbB ReceptorsIridoid GlucosidesgentiopicrosideEGFR protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, China.

ORCID-Profile: Zhang Nan, Heng Zhou

Förderung

  • National Natural Science Foundation of China
  • Health Commission of Hubei Province scientific research project

Zitieren

APA

Cao, M., Ke, D., Ni, J., Yuan, Y., Nan, Z., Dai, X., & Zhou, H. (2026). Gentiopicroside Regulates EGFR and Induces Its Lysosomal Degradation to Attenuate Heart Failure. Phytotherapy Research, 40(11), 6670-6684. https://doi.org/10.1002/ptr.70452

Vancouver

Cao M, Ke D, Ni J, Yuan Y, Nan Z, Dai X, et al. Gentiopicroside Regulates EGFR and Induces Its Lysosomal Degradation to Attenuate Heart Failure. Phytotherapy Research. 2026;40(11):6670-6684. doi:10.1002/ptr.70452

BibTeX
@article{Cao2026,
  author = {Cao, Mingzhen and Ke, Da and Ni, Jian and Yuan, Yuan and Nan, Zhang and Dai, Xiujun and Zhou, Heng},
  title = {Gentiopicroside Regulates EGFR and Induces Its Lysosomal Degradation to Attenuate Heart Failure},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6670--6684},
  doi = {10.1002/ptr.70452}
}
Kostenlos starten →